Canadian Institutes of Health Research

Canadian Rare Diseases Models and Mechanisms network receives C$2.3 million to support model organism research

NEW YORK (GenomeWeb) – Four Canadian government research funding agencies will spend around C$7.3 million (US$6.7 million) to create a cloud computing facility and data mining tools that will enable researchers to access and use data from the International Cancer Genome Consortium.

NEW YORK (GenomeWeb News) – The Canadian Institutes of Health Research and Genome Canada plan to provide C$2.3 million (US$2.2 million) to fund a national network to help clinical researchers studying genes involved in rare diseases to partner with experts in model organisms, CIHR said yesterday.

NEW YORK (GenomeWeb News) – Canada's government has awarded C$10 million (US$9.7 million) to fund a research program at McGill University focused on pain genetics that will be headed by Luda Diatchenko, McGill said yesterday.

This article has been updated with a comment from one of the researchers regarding which tests will be included in the study.

NEW YORK (GenomeWeb News) – Genome Canada and the Canadian Institutes of Health Research said today that a number of new genomics and personalized medicine research projects focused on tackling common, complex, and rare diseases have received C$150 million (US$147.5 million) in new grants.

NEW YORK (GenomeWeb News) – The Canadian government has invested C$19 million (US$19.3 million) in new collaborative research projects to develop a range of biomedical technologies including tools to advance microfluidics, mass spectrometry, and drug screening.

NEW YORK (GenomeWeb News) – Genome Canada and the Canadian Institute of Health Research will award C$6.3 million (US$6.1 million) to research projects under its 2012 Bioinformatics and Computational Biology Competition to develop new tools to deal with the large volumes of data being generated fr

The device, named the Verisante Aura, uses Raman spectroscopy to measure levels of various biomarkers – including proteins, nucleic acids, and metabolites – in skin lesions. In initial clinical trials it distinguished between benign and malignant lesions with 100-percent sensitivity and 70-percent specificity.

Two groups funded by Genome Canada and the Canadian Institutes of Health Research will use sequencing-based studies to identify genes involved in pediatric genetic diseases and childhood cancers.

Pages

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.